BRIEF published on 12/16/2025 at 21:23, 10 months 26 days ago ABIONYX Pharma Announces €1.8 Million Capital Increase Capital Increase Subscription Rights Euronext Listing ABIONYX Pharma Financial Visibility
BRIEF published on 12/16/2025 at 21:23, 10 months 26 days ago ABIONYX Pharma Annonce une Augmentation de Capital Augmentation De Capital Biopharmaceutique Levée De Fonds ABIONYX Pharma Sepsis
BRIEF published on 12/16/2025 at 21:23, 10 months 26 days ago ABIONYX Pharma annonce une augmentation de capital de 1,8 million d'euros. Augmentation De Capital Cotation Euronext Visibilité Financière ABIONYX Pharma Droits D'abonnement
BRIEF published on 12/16/2025 at 21:23, 10 months 26 days ago ABIONYX Pharma Announces a Capital Increase Fundraising Capital Increase Biopharmaceutical ABIONYX Pharma Sepsis
PRESS RELEASE published on 12/16/2025 at 21:18, 10 months 26 days ago Inside Information / Other news releases ABIONYX Pharma launches €1.8m capital increase with removal of preferential subscription rights, subscription price at 3.10 euros for new shares, extending financial visibility until 2026 Capital Increase Biopharma Preferential Subscription Rights ABIONYX Pharma Financial Visibility
PRESS RELEASE published on 12/16/2025 at 21:18, 10 months 26 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma lance une augmentation de capital de 1,8M€ avec suppression du droit préférentiel de souscription à 3,10 euros par action et extension de la visibilité jusqu'à fin 2026 Augmentation De Capital Droit Préférentiel De Souscription ABIONYX Pharma Visibilité 3,10 Euros
BRIEF published on 12/05/2025 at 18:05, 11 months 6 days ago ABIONYX Reports Monthly Voting Rights and Share Data Euronext Paris Share Capital Voting Rights AMF Regulations ABIONYX Pharma
BRIEF published on 12/05/2025 at 18:05, 11 months 6 days ago ABIONYX publie des données mensuelles sur les droits de vote et les actions Euronext Paris Capital Social Droit De Vote ABIONYX Pharma Règlementation De L'AMF
PRESS RELEASE published on 12/05/2025 at 18:00, 11 months 6 days ago Inside Information / Other news releases ABIONYX Pharma discloses monthly statement of total voting rights and shares as per French regulations. Company focused on innovative medicines in rare diseases Shares French Regulations Total Voting Rights ABIONYX Pharma Innovative Medicines
BRIEF published on 11/25/2025 at 18:38, 11 months 16 days ago ABIONYX Pharma Releases Q3 2025 Business Update Revenue Financial Update ABIONYX Pharma Q3 2025 Sepsis Research
Published on 11/12/2026 at 14:31, 1 hour 9 minutes ago First Breach Inc. Announces Third Quarter 2026 Earnings Conference Call
Published on 11/12/2026 at 14:00, 1 hour 40 minutes ago GameSquare Announces Peaky Blinders Digital Fan Experience, Advancing the Company's IP Monetization Strategy
Published on 11/12/2026 at 14:00, 1 hour 40 minutes ago NuRAN Wireless Highlights Recurring Revenue Economics and Growth Potential of Its 5,092-Tower Contracted NaaS Portfolio
Published on 11/12/2026 at 13:45, 1 hour 55 minutes ago Amarc and Freeport Successfully Complete 2026 Joy Copper-Gold District Exploration Program
Published on 11/12/2026 at 13:30, 2 hours 10 minutes ago Nextech3D.ai to Present at the Small Cap Growth Virtual Investor Conference November 18th at 12:30 p.m. ET
Published on 11/12/2026 at 15:09, 30 minutes ago EQS-Adhoc: Starcom Holding AD: Payment under Corporate Bonds
Published on 11/12/2026 at 15:00, 39 minutes ago Clemta Expands Partner API to Power End-to-End U.S. Business Services
Published on 11/12/2026 at 14:56, 44 minutes ago Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 11/12/2026 at 08:56, 6 hours 43 minutes ago Number of shares and voting rights - October 2026 (In French only)
Published on 11/12/2026 at 08:56, 6 hours 43 minutes ago Nombre total d'actions et droits de vote - octobre 2026
Published on 11/12/2026 at 08:40, 7 hours ago FREY forms a €400 million equity partnership with GIC to invest in premium European retail parks
Published on 11/12/2026 at 08:40, 7 hours ago FREY et GIC s’associent pour investir 400 M€ de capital dans les retail parks premium en Europe
Published on 11/10/2026 at 18:00, 1 day 21 hours ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
